Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study

Published:2000-01-12 Issue:2 Volume:45 Page:177-181
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Merimsky Ofer,Meller Isaac,Flusser Gidon,Kollender Yehuda,Issakov Josephine,Weil-Ben-Arush Miriam,Fenig Eyal,Neuman Gad,Sapir Dov,Ariad Shmuel,Inbar Moshe

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s002800050027.pdf

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biology and treatment of leiomyosarcomas;Critical Reviews in Oncology/Hematology;2023-04

2. Uterine leiomyosarcoma;Diagnosis and Treatment of Rare Gynecologic Cancers;2023

3. Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study;Cancer Medicine;2022-08-15

4. Recent and Ongoing Research into Metastatic Osteosarcoma Treatments;International Journal of Molecular Sciences;2022-03-30

5. Soft Tissue Sarcomas with Special Reference to Molecular Aberration, Chemotherapy, and Recent Advances: A Review Article;Indian Journal of Medical and Paediatric Oncology;2022-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP